Giverny Capital Asset Management, LLC, an investment management company, recently published its fourth-quarter 2024 investor ...
Morgan Stanley analyst Erin Wright lowered the firm’s price target on Align Technology (ALGN) to $272 from $280 and keeps an Overweight rating ...
Baird lowered the firm’s price target on Align Technology (ALGN) to $250 from $276 and keeps an Outperform rating on the shares. The firm said ...
Piper Sandler adjusted its price target on Align Technology stock, listed on (NASDAQ:ALGN), from $275.00 to $270.00, while maintaining an Overweight rating. The dental technology company, currently ...
The stock's fall snapped a two-day winning streak.
Align Technology reports $4 billion in total revenue for 2024 fiscal year, with clear aligner sales accounting for $3.2 billion.
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign ® System of clear aligners ...
Please note this conference is being recorded. I will now turn the conference over to your host, Shirley Stacy with Align Technology. You may begin. Shirley Stacy-- Vice President, Corporate and ...
Align Technology shares have risen almost 4% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $216.74, a decrease of 21% in the last 12 months.
Currency fluctuations negatively impacted earnings. Align Technology reported earnings that aligned closely with expectations, highlighting international growth amid currency challenges.
In its fourth quarter 2024 investor letter, Giverny Capital Asset Management emphasized stocks such as Align Technology, Inc. (NASDAQ:ALGN). Align Technology, Inc. (NASDAQ:ALGN) designs ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results